The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

Noni E. MacDonald; Jane C. McDonald; Natalie A. Bridger; Jane C. Finlay; Susanna Martin; Heather Onyett; Joan L. Robinson; Marina I. Salvadori; Otto G. Vanderkooi

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

Noni E. MacDonald, Jane C. McDonald, Natalie A. Bridger, Jane C. Finlay, Susanna Martin, Heather Onyett, Joan L. Robinson, Marina I. Salvadori, Otto G. Vanderkooi

Medicine

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight.

Original language	English
Journal	Paediatrics and Child Health
Volume	19
Issue number	10
Publication status	Published - Dec 1 2014

Bibliographical note

Publisher Copyright:
© 2014 Pulsus Group Inc. All rights reserved.

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ce2b44051c494b81a44de2c532e89ff2,

title = "The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age",

abstract = "Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight.",

author = "MacDonald, {Noni E.} and McDonald, {Jane C.} and Bridger, {Natalie A.} and Finlay, {Jane C.} and Susanna Martin and Heather Onyett and Robinson, {Joan L.} and Salvadori, {Marina I.} and Vanderkooi, {Otto G.}",

year = "2014",

month = dec,

day = "1",

language = "English",

volume = "19",

journal = "Paediatrics and Child Health",

issn = "1205-7088",

publisher = "Pulsus Group Inc.",

number = "10",

}

TY - JOUR

T1 - The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

AU - MacDonald, Noni E.

AU - McDonald, Jane C.

AU - Bridger, Natalie A.

AU - Finlay, Jane C.

AU - Martin, Susanna

AU - Onyett, Heather

AU - Robinson, Joan L.

AU - Salvadori, Marina I.

AU - Vanderkooi, Otto G.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight.

AB - Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight.

UR - http://www.scopus.com/inward/record.url?scp=84916939978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916939978&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84916939978

SN - 1205-7088

VL - 19

JO - Paediatrics and Child Health

JF - Paediatrics and Child Health

IS - 10

ER -

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

Abstract

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Other files and links

Fingerprint

Cite this